CCL18 and hepatocellular carcinoma: Our investigation demonstrated that exogenous CCL18 enhances key oncogenic processes in HCC cell lines LM3 and MHCC-97H, including proliferation, migration, invasion, and up-regulation of the immune-suppressive marker PD-L1 protein.